SCHEMBL7422887

SCHEMBL7422887

CCn1ncc2c(NCc3ccc(OC)c(OC)c3)c3ccccc3nc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 9/20 0.57
BCHE P06276 6/20 0.57
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
KDM4E B2RXH2 1/20 0.54
TTR P02766 1/20 0.54
GLA P06280 1/20 0.54
POLB P06746 1/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
RAD52 P43351 1/20 0.54
PDE5A O76074 3/20 0.54
APP P05067 6/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
THRB P10828 1/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416586 0.86 EGFR (0.52) CYP1A2CYP3A4POLBGAAMAPT
SCHEMBL7418464 0.86 APP (0.53) CYP1A2CYP3A4POLBGAAMAPT
Hydrochloric Acid SCHEMBL7423114 0.85 EGFR (0.51) CYP1A2CYP3A4POLBGAAMAPT
SCHEMBL7028354 0.85 KMT2A (0.60) ACHEBCHEKDM4EPOLBMAPT
SCHEMBL7423097 0.82 POLB (0.48) ACHEBCHEPOLBRAD52PDE5A
SCHEMBL7420540 0.82 POLB (0.50) ACHEBCHEPOLBRAD52PDE5A
SCHEMBL7420650 0.81 PDE5A (0.50) ACHEBCHECYP1A2CYP3A4KDM4E
SCHEMBL7418635 0.81 POLB (0.51) KDM4EPOLBMAPTRAD52PDE5A
SCHEMBL7421877 0.80 TACR3 (0.51) KDM4EPOLBMAPTRAD52PDE5A
SCHEMBL8444030 0.79 ALDH1A1 (0.50) CYP1A2CYP3A4KDM4EGLAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008226-A AN ENZYME INHIBITOR OF C-GMP-PHOSPHODIESTERASE FOR TREATING HEART FAILURE, HYPERTENSION, REVERSING OR REDUCING NITRATE-INDUCED TOLERANCE AND ANGINA PECTORIS, CONGESTIVE HEART DISEASE AND MYOCARDIAL INFARCTION SANOFI-SYNTHELABO (FR) 1999-12-28 US disclosed
US-5852035-A Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines CELL PATHWAYS, INC. (US) 1998-12-22 US disclosed
US-5843956-A Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof SANOFI (FR) 1998-12-01 US disclosed
US-5614530-A GMP PHOSPHODIESTERASE INHIBITOR, HYPOTENSIVE STERLING WINTHROP INC. (US) 1997-03-25 US disclosed
WO-1996028159-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed